# Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia

> **NCT01066286** · — · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01066286
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066286, "Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01066286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*